anti-psma/steap1 antibody-drug conjugate abbv-969
Generic: Anti-PSMA/STEAP1 Antibody-drug Conjugate ABBV-969
anti-psma/steap1 antibody-drug conjugate abbv-969: 1 clinical trial tracked.
anti-psma/steap1 antibody-drug conjugate abbv-969 evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about anti-psma/steap1 antibody-drug conjugate abbv-969, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence0 indications · 1 study sponsors
Related indications
No linked indication is available.
Study sponsors
Clinical Trial Registry Records (1)
A Phase 1 First-in-Human Study Evaluating Safety, Pharmacokinetics, and Efficacy of ABBV-969 in Adult Subjects With Metastatic Castration-Resistant Prostate Cancer
Primary endpoint: Percentage of Participants With Adverse Events (AEs)
Interventionalopen152 targetStarted 2024-03Completion 2027-0526 sites · Australia, Canada, France, Israel…AbbVie